LN6468651
Valsartanbenzylester , 98% , 137863-20-8
Synonym(s):
(S)-N-Valeryl-N-([2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl)valine benzyl ester;(N-VALERYL-N-{[2’-(1HTETRAZOLE-5-YL)BIPHENYL-4-YL]METHYL}-L-VALINEBENZYL ESTER);N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L -valine phenylmethyl ester
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB1489.60 | In Stock |
|
| 50MG | RMB5585.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >71°C (dec.) |
| Boiling point: | 720.1±70.0 °C(Predicted) |
| Density | 1.180±0.06 g/cm3(Predicted) |
| vapor pressure | 0-0Pa at 20-25℃ |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| pka | 4.15±0.10(Predicted) |
| form | solid |
| color | White to Off-White |
| LogP | 2.43 at 25℃ and pH7.35 |
| Surface tension | 59.6-68.1mN/m at 10-100mg/L and 20℃ |
Description and Uses
Valsartan (V095750) intermediate. Valsartan USP Related Compound C.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312-P330-P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| HS Code | 2933997500 |





![5-(4'-methyl-[1,1'-biphenyl]-2-yl)-1H-tetrazole](https://img.chemicalbook.com/CAS/GIF/120568-11-8.gif)
![(R)-2-(N-((2''-(1H-Tetrazol-5-yl)-[1,1''-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicacid](https://img.chemicalbook.com/CAS/GIF/137862-87-4.gif)
